Jean Michel Cayuela

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years

Philippe Rousselot, Françoise Huguet, Delphine Réa et al. · Blood · 2006 · 530 citations

Pharmacy, Hematology, Pharmacotherapy +3

Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease

Philippe Rousselot, Aude Charbonnier, Pascale Cony‐Makhoul et al. · Journal of Clinical Oncology · 2013 · 409 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia

Irene Homminga, Rob Pieters, Anton W. Langerak et al. · Cancer Cell · 2011 · 382 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.

Michel Bahuau, Dominique Vidaud, Robert B. Jenkins et al. · PubMed · 1998 · 165 citations

Life Sciences, Genetics, Molecular Genetics +17

The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia

Fanny Legrand, Aline Renneville, Elizabeth Macintyre et al. · Medicine · 2013 · 99 citations

Medicine, Hematology, Pharmacotherapy +12